| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |